Cite
Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar.
MLA
Gutman, Sarah J., et al. “Reduction in Mortality from Implantable Cardioverter-Defibrillators in Non-Ischaemic Cardiomyopathy Patients Is Dependent on the Presence of Left Ventricular Scar.” European Heart Journal, vol. 40, no. 6, Feb. 2019, pp. 542–50. EBSCOhost, https://doi.org/10.1093/eurheartj/ehy437.
APA
Gutman, S. J., Costello, B. T., Papapostolou, S., Voskoboinik, A., Iles, L., Ja, J., Hare, J. L., Ellims, A., Kistler, P. M., Marwick, T. H., & Taylor, A. J. (2019). Reduction in mortality from implantable cardioverter-defibrillators in non-ischaemic cardiomyopathy patients is dependent on the presence of left ventricular scar. European Heart Journal, 40(6), 542–550. https://doi.org/10.1093/eurheartj/ehy437
Chicago
Gutman, Sarah J, Benedict T Costello, Stavroula Papapostolou, Aleksandr Voskoboinik, Leah Iles, Johnson Ja, James L Hare, et al. 2019. “Reduction in Mortality from Implantable Cardioverter-Defibrillators in Non-Ischaemic Cardiomyopathy Patients Is Dependent on the Presence of Left Ventricular Scar.” European Heart Journal 40 (6): 542–50. doi:10.1093/eurheartj/ehy437.